These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 19227153)
21. Drug resistance and multi-drug therapy in leprosy. Chatterjee BR Lepr India; 1982 Jul; 54(3):402-11. PubMed ID: 6757576 [No Abstract] [Full Text] [Related]
22. WHO regional strategy for sustaining leprosy services and further reducing the burden of leprosy, 2006-2010. WHO Regional Office for South-East Asia Indian J Lepr; 2006; 78(1):33-47. PubMed ID: 16646282 [No Abstract] [Full Text] [Related]
23. An 8-12 year follow-up of highly bacillated Indian leprosy patients treated with WHO multi-drug therapy. Desikan KV; Sundaresh P; Tulasidas I; Rao PV Lepr Rev; 2008 Sep; 79(3):303-10. PubMed ID: 19009979 [TBL] [Abstract][Full Text] [Related]
24. Report of workshop on defining the disease and antibacterial therapy. Jacobson RR Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):572-3. PubMed ID: 10347574 [No Abstract] [Full Text] [Related]
25. 'Final push of leprosy' in India: What is being pushed? Rao PN; Lakshmi TS Indian J Dermatol Venereol Leprol; 2005; 71(4):226-9. PubMed ID: 16394428 [No Abstract] [Full Text] [Related]
26. Leprosy at a turning point? Harboe M Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095 [No Abstract] [Full Text] [Related]
27. Multi-drug therapy in leprosy. Girdhar BK Indian J Lepr; 1987; 59(2):145-51. PubMed ID: 3309084 [No Abstract] [Full Text] [Related]
28. From vertical to integration for elimination: recent changes in the National Leprosy Eradication Programme in India. Thakar HG; Kumar A Indian J Public Health; 2003; 47(4):191-207. PubMed ID: 15125562 [No Abstract] [Full Text] [Related]
29. Report of the ninth meeting of the WHO Technical Advisory Group on Leprosy Control: Cairo, Egypt, 6-7 March 2008. World Health Organisation Lepr Rev; 2008 Dec; 79(4):452-70. PubMed ID: 19274996 [No Abstract] [Full Text] [Related]
30. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs. Almeida JG Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367 [No Abstract] [Full Text] [Related]
31. Leprosy: a review on elimination, reducing the disease burden, and future research. Chaptini C; Marshman G Lepr Rev; 2015 Dec; 86(4):307-15. PubMed ID: 26964426 [TBL] [Abstract][Full Text] [Related]
33. The national leprosy eradication programme in India. Mittal BN World Health Stat Q; 1991; 44(1):23-9. PubMed ID: 2068822 [TBL] [Abstract][Full Text] [Related]
34. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally. Lockwood DN; Cunha Mda G Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024 [No Abstract] [Full Text] [Related]
35. [Future strategies for global leprosy control, 2011-2015]. Mori S; Suzuki K; Barua S; Nagaoka Y; Ishii N Nihon Hansenbyo Gakkai Zasshi; 2010 Feb; 79(1):53-73. PubMed ID: 20169985 [TBL] [Abstract][Full Text] [Related]
38. An update on the diagnosis and treatment of leprosy. Moschella SL J Am Acad Dermatol; 2004 Sep; 51(3):417-26. PubMed ID: 15337986 [No Abstract] [Full Text] [Related]
39. Leprosy elimination campaign in Qazvin province, Islamic Republic of Iran (2006-07). Qasemi-Barqi R; Bijani B; Pahlevan AA East Mediterr Health J; 2011 Dec; 17(12):920-4. PubMed ID: 22355944 [TBL] [Abstract][Full Text] [Related]
40. Is there a microbiological rationale for single-dose treatment of leprosy? Katoch VM Lepr Rev; 1998 Mar; 69(1):2-5. PubMed ID: 9628091 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]